‘Infectious disease technology’ refers to 1) camera-based detection tools that use thermal imaging and facial recognition, 2) surveillance gadgets (smart wearables), and 3) software platforms that convert data to identify individuals (i.e. to trace contacts and share system-generated insights in real-time). The software tools often include the latest artificial intelligence (AI) and machine learning capabilities that allow end-to-end, seamless, actionable insights. These detection tools are now being promoted to the masses in response to the Covid-19 pandemic, including for implementation in office spaces.
Players often provide the hardware and software in combination, although several operate as pure-play software providers. This report does not cover clinical/medicinal diagnostic methods such as PCR testing, as they are unlikely to be used outside of the healthcare industry.
Note: Additional sections (such as market sizing and incumbents) can be provided on request.
Many incumbents and disruptors in the industry offer integrated hardware and software solutions. However, there are still a considerable number of pure-play operators generally breaking down as hardware-only incumbents and software-only disruptors, most of which have capitalized on the emergence of contact tracing and self quarantine activities.
Disruptors in the industry include startups involved in the manufacture and installation of equipment relating to infectious diseases. On the software side, disruptors include companies that specialize in AI and machine learning platforms integrated with surveillance equipment to run contact tracing. These forms of surveillance tech startups have quickly launched new products and websites for the opportunity to sell surveillance tools and platforms to businesses.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.